Radiomics-driven prediction of pathologic complete response in non-mass breast cancer using post-neoadjuvant chemotherapy preoperative dynamic contrast-enhanced magnetic resonance imaging

Accurate early prediction of pCR could help identify patients most likely to benefit from NAC and avoid ineffective treatment in non-responders. The developed radiomics model offers an interpretable and reproducible tool; upon successful external validation, it has the potential to support personalized treatment planning in patients with NML-type breast cancer.